CNOT6 deadenylase safeguards postnatal growth and metabolic transition via Fgf21 mRNA decay

This study identifies CNOT6 as an essential post-transcriptional regulator that ensures healthy postnatal growth and metabolic transition by promoting the decay of Fgf21 mRNA, thereby preventing excessive FGF21 expression that would otherwise suppress anabolic metabolism and cause severe growth retardation.

The Gist

Imagine a baby mouse as a tiny construction site. To grow from a newborn into a healthy adult, this site needs two things working in perfect harmony: bricks and mortar (building new tissue) and power (energy to run the cranes and mix the cement).

For a long time, scientists knew about the "foreman" who manages the energy supply in adult mice, but they didn't know who was in charge of the construction crew during the critical newborn phase.

This paper introduces a new character: a molecular protein called CNOT6. Think of CNOT6 as a strict but necessary "Recycling Manager" for the baby mouse's liver.

Here is the story of what happens when this manager is missing, explained through simple analogies:

1. The Twin Brothers: CNOT6 and CNOT6L

The mouse has two very similar proteins, like twin brothers: CNOT6 and CNOT6L.

• CNOT6L is the older brother who works in the adult mouse. He helps the adult mouse burn fat and stay lean. If you remove him, the adult mouse is fine, just a bit different metabolically.
• CNOT6 is the younger brother who works only in the baby. He is the key to getting the baby to grow big and strong.

2. The "Stop Sign" That Was Missing

In a healthy baby mouse, the liver produces a hormone called FGF21. You can think of FGF21 as a "Stop and Burn" sign.

• When FGF21 is high, it tells the body: "Stop building new muscle and fat. Instead, burn your existing fat for energy." This is great for an adult who is fasting or trying to lose weight.
• But for a baby? This is a disaster. A baby needs to be in "Build Mode" (anabolism), not "Burn Mode" (catabolism).

Enter CNOT6: Its job is to act as a trash collector for the FGF21 instructions. It finds the "Stop and Burn" messages (mRNA) and throws them in the recycling bin so they don't get read. This keeps FGF21 levels low, allowing the baby to focus entirely on growing.

3. What Happens When CNOT6 is Gone?

The researchers removed the CNOT6 gene (the Recycling Manager) from the mice. Here is the chaos that ensued:

• The Trash Pile-Up: Without the manager, the "Stop and Burn" instructions (FGF21) piled up in the liver. The cell was drowning in messages telling it to stop growing.
• The Construction Site Halts: Because the "Stop" signal was so loud, the baby mice stopped building. They became tiny, with organs (like the liver and heart) that were much smaller than normal.
• The "Starvation" State: Even though the baby mice were eating, their bodies thought they were starving. They started burning fat for fuel (producing ketones) instead of using that fuel to build new tissue.
• The Result: Many of these baby mice died before they could even wean. Those that survived were very small at first, but eventually, they managed to "catch up" in size as they got older, proving that the system has a backup plan, but it's a very rough start.

4. The Big Picture: Why This Matters

This study reveals a hidden switch in our biology.

• In Adults: We need to burn fat to stay healthy (controlled by the other twin, CNOT6L).
• In Babies: We need to build fat and muscle to survive (controlled by CNOT6).

The paper shows that nature has a specific "molecular checkpoint" (CNOT6) that ensures babies don't accidentally switch into "diet mode" while they are trying to grow. If this switch breaks, the baby's body gets confused, thinking it needs to conserve energy by stopping growth, leading to severe stunting.

The Takeaway

Think of CNOT6 as the guardian of the nursery. Its sole job is to silence the "diet" signals so the baby can focus 100% on growing up. Without this guardian, the baby's body mistakenly thinks it's time to fast, and the construction of a healthy life grinds to a halt.

This discovery helps us understand why some children fail to grow despite eating enough food, and it suggests that fixing this "recycling" mechanism could one day help treat growth disorders.

Technical Summary

1. Problem Statement

Postnatal growth and development require a precise coordination between anabolic growth pathways and metabolic adaptation to meet the energetic demands of rapidly expanding organs. While endocrine regulators like Growth Hormone (GH), Insulin-like Growth Factor 1 (IGF1), and Fibroblast Growth Factor 21 (FGF21) are known to link nutrient availability to growth, the post-transcriptional mechanisms governing the transition from fetal to postnatal metabolism remain poorly understood.

Specifically, the CCR4-NOT complex is the major eukaryotic deadenylase machinery responsible for mRNA decay. Previous studies established that the paralog CNOT6L regulates systemic metabolism and FGF21 expression in adult mice. However, the physiological role of its paralog, CNOT6, during the critical neonatal period, and whether it plays a distinct role in coordinating early-life growth and metabolic reprogramming, was unknown.

2. Methodology

The study employed a multi-faceted approach combining genetic models, transcriptomics, and metabolic profiling:

• Genetic Models:
  • Cnot6 Knockout (KO) Mice: Generated using a targeted gene-trap strategy (insertion of lacZ, neomycin resistance, and polyA signal between exons 3 and 4) to create a null allele.
  • Cnot6l KO Mice: Utilized existing models to serve as a comparative control for the paralog.
  • Phenotyping: Mice were monitored from birth (P0) through adulthood (8 weeks). Parameters included body weight, nose-to-anus length, tibia length, and organ weights (liver, kidney, heart, spleen, brain). Genotyping was performed to assess Mendelian ratios and perinatal survival rates.
• Molecular Analysis:
  • qPCR & Western Blot: Validated mRNA and protein levels of CNOT6, FGF21, IGF1, and IGFBP1 in various tissues (liver, kidney, brain, etc.) at 2 weeks of age.
  • Bulk RNA-Sequencing (RNA-seq): Performed on liver tissues of 2-week-old WT and Cnot6 KO mice (3 biological replicates). Data was processed using standard pipelines (FastQC, Trimmomatic, HISAT2, StringTie, DESeq2) to identify Differentially Expressed Genes (DEGs).
  • Bioinformatics: Gene Set Enrichment Analysis (GSEA) and pathway enrichment were conducted using clusterProfiler to identify altered biological processes.
• Metabolic Assays:
  • Serum Analysis: Measured blood glucose and serum $\beta$-hydroxybutyrate (ketone bodies) to assess glucose handling and fatty acid oxidation status.

3. Key Contributions

• Discovery of Developmental Specialization: The study establishes that CNOT6 and CNOT6L, despite sharing >80% sequence identity and similar enzymatic activity, have stage-specific physiological roles. CNOT6L is critical for adult metabolic homeostasis, whereas CNOT6 is essential for neonatal growth and survival.
• Mechanistic Link to FGF21: The authors identify CNOT6 as the primary deadenylase responsible for degrading Fgf21 mRNA during the neonatal period. Loss of CNOT6 leads to the accumulation of Fgf21 transcripts.
• The CNOT6-FGF21-IGF1 Axis: The paper elucidates a novel molecular checkpoint where CNOT6-mediated repression of FGF21 is required to maintain the IGF1-IGFBP1 axis, which is crucial for anabolic growth.

4. Key Results

A. Phenotypic Consequences of CNOT6 Loss

• Severe Growth Retardation: Cnot6 KO mice exhibited significantly reduced body weight, body length, and tibia length at 2 weeks of age compared to WT littermates.
• Organ Hypoplasia: KO mice displayed multi-organ hypoplasia, with significantly reduced weights of the liver, kidneys, spleen, and heart.
• Perinatal Lethality: Genotyping revealed a significant deviation from Mendelian ratios. Only ~33% of expected KO mice survived to 2 weeks, with ~54% of expected KO pups present at birth (P0), indicating substantial perinatal mortality.
• Catch-up Growth: Surviving KO mice gradually normalized in size by 8 weeks, suggesting developmental compensation mechanisms.
• Paralog Specificity: In contrast, Cnot6l KO mice showed no defects in early postnatal growth or organ size, confirming functional segregation.

B. Molecular Mechanisms

• FGF21 Accumulation: Cnot6 KO livers showed a marked increase in Fgf21 mRNA levels.
• Suppression of IGF1 Signaling: Elevated FGF21 led to the downregulation of Igf1 and upregulation of Igfbp1 (Insulin-like Growth Factor Binding Protein 1), effectively suppressing the IGF1 signaling axis required for linear growth.
• Transcriptomic Reprogramming: RNA-seq revealed 378 DEGs.
  • Downregulated: Genes involved in lipid biosynthesis and carbohydrate metabolism (e.g., Lpin1, Gck, Gpt).
  • Upregulated: Genes associated with apoptosis, stress response, and fatty acid oxidation (e.g., Pdk4, Nr4a1, Gzma).
• Metabolic Shift: KO mice exhibited elevated serum ketone bodies ($\beta$-hydroxybutyrate) and blood glucose, indicating a shift toward catabolic metabolism (fatty acid oxidation) and impaired glucose clearance, mimicking a "fasting-like" state inappropriate for a growing neonate.

C. Expression Dynamics

• Cnot6 mRNA expression is highest in the liver during the fetal and early postnatal periods (peaking at E14.5 to 2 weeks) and declines in adulthood, coinciding with the rise of Cnot6l. This temporal expression pattern supports its role in the metabolic transition from placental to independent energy supply.

5. Significance

• Novel Regulatory Axis: This work uncovers the CNOT6-FGF21 axis as a critical molecular checkpoint coupling mRNA decay to hormonal and metabolic coordination. It explains how the body prevents premature activation of catabolic programs (mediated by FGF21) during the anabolic neonatal window.
• Clinical Relevance: The findings provide a mechanistic basis for understanding human growth disorders. Elevated FGF21 levels are observed in preterm infants with growth failure, children with idiopathic short stature, and adolescents with anorexia nervosa. The study suggests that dysregulation of mRNA decay machinery (specifically CNOT6 function) could underlie these conditions, offering new therapeutic targets beyond current nutritional or GH-based interventions.
• Evolutionary Insight: The stage-specific utilization of CNOT6 vs. CNOT6L represents an adaptive mechanism to reprogram the mRNA decay landscape, ensuring that the metabolic priorities of rapid tissue expansion (anabolism) are prioritized over energy conservation (catabolism) during early life.

In summary, the paper demonstrates that CNOT6 is a non-redundant guardian of postnatal growth, acting by degrading Fgf21 mRNA to prevent growth suppression and ensure the metabolic environment supports rapid organ development.